Literature DB >> 28835500

Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.

Jayashree Thatte1, Lawrence Banks2.   

Abstract

The human papillomavirus (HPV) E6 oncoproteins recruit the cellular ubiquitin ligase E6AP/UBE3A to target cellular substrates for proteasome-mediated degradation, and one consequence of this activity is the E6 stimulation of E6AP autoubiquitination and degradation. Recent studies identified an autism-linked mutation within E6AP at T485, which was identified as a protein kinase A phosphoacceptor site and which could directly regulate E6AP ubiquitin ligase activity. In this study, we have analyzed how T485-mediated regulation of E6AP might affect E6 targeting of some of its known substrates. We show that modulation of T485 has no effect on the ability of E6 to direct either p53 or Dlg for degradation. Furthermore, T485 regulation has no effect on HPV-16 or HPV-31 E6-induced autodegradation of E6AP but does affect HPV-18 E6-induced autodegradation of E6AP. In cells derived from cervical cancers, we find low levels of both phosphorylated and nonphosphorylated E6AP in the nucleus. However, ablation of E6 results in a dramatic accumulation of phospho-E6AP in the cytoplasm, whereas nonphosphorylated E6AP accumulates primarily in the nucleus. Interestingly, E6AP phosphorylation at T485 confers association with 14-3-3 proteins, and this interaction seems to be important, in part, for the ability of E6 to recruit phospho-E6AP into the nucleus. These results demonstrate that HPV E6 overrides the normal phosphoregulation of E6AP, both in terms of its enzymatic activity and its subcellular distribution.IMPORTANCE Recent reports demonstrate the importance of phosphoregulation of E6AP for its normal enzymatic activity. Here, we show that HPV E6 is capable of overriding this regulation and can promote degradation of p53 and Dlg regardless of the phosphorylation status of E6AP. Furthermore, E6 interaction with E6AP also significantly alters how E6AP is subject to autodegradation and suggests that this is not a simple stimulation of an already-existing activity but rather a redirection of E6AP activity toward itself. Furthermore, E6-mediated regulation of the subcellular distribution of phospho-E6AP appears to be dependent, in part, upon the 14-3-3 family of proteins.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  E6AP; HPV E6; phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28835500      PMCID: PMC5660492          DOI: 10.1128/JVI.01390-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.

Authors:  M Thomas; G Matlashewski; D Pim; L Banks
Journal:  Oncogene       Date:  1996-07-18       Impact factor: 9.867

2.  Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells.

Authors:  P R Daniels; C M Sanders; N J Maitland
Journal:  J Gen Virol       Date:  1998-03       Impact factor: 3.891

3.  HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.

Authors:  D Pim; M Thomas; R Javier; D Gardiol; L Banks
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

4.  Inhibition of Bak-induced apoptosis by HPV-18 E6.

Authors:  M Thomas; L Banks
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

5.  The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.

Authors:  Vjekoslav Tomaić; David Pim; Lawrence Banks
Journal:  Virology       Date:  2009-08-22       Impact factor: 3.616

6.  Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination.

Authors:  Franziska Mortensen; Daniel Schneider; Tanja Barbic; Anna Sladewska-Marquardt; Simone Kühnle; Andreas Marx; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

7.  siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.

Authors:  Karin Butz; Tutik Ristriani; Arnd Hengstermann; Claudia Denk; Martin Scheffner; Felix Hoppe-Seyler
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

8.  14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination.

Authors:  Zhenming Xu; Zsolt Fulop; Guikai Wu; Egest J Pone; Jinsong Zhang; Thach Mai; Lisa M Thomas; Ahmed Al-Qahtani; Clayton A White; Seok-Rae Park; Petra Steinacker; Zenggang Li; John Yates; Bruce Herron; Markus Otto; Hong Zan; Haian Fu; Paolo Casali
Journal:  Nat Struct Mol Biol       Date:  2010-08-22       Impact factor: 15.369

9.  A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor.

Authors:  Mojgan Padash Barmchi; Mary Gilbert; Miranda Thomas; Lawrence Banks; Bing Zhang; Vanessa J Auld
Journal:  PLoS Pathog       Date:  2016-08-18       Impact factor: 6.823

Review 10.  The biology and life-cycle of human papillomaviruses.

Authors:  John Doorbar; Wim Quint; Lawrence Banks; Ignacio G Bravo; Mark Stoler; Tom R Broker; Margaret A Stanley
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

View more
  3 in total

1.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

2.  Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).

Authors:  Arushi Vats; Oscar Trejo-Cerro; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

Review 3.  Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response.

Authors:  Nicholas A Mathieu; Rafael H Levin; Donald E Spratt
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.